Lillemor Melander Skattum
11 – 20 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
(
- Contribution to journal › Article
- 2019
-
Mark
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use
(
- Contribution to journal › Article
-
Mark
Analysis of C3 nephritic factors by ELISA
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Analysis of anti-C1q autoantibodies by western blot
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Clinical Complement Analysis—An Overview
(
- Contribution to journal › Scientific review
-
Mark
Serum complexes between C1INH and C1INH autoantibodies for the diagnosis of acquired angioedema
(
- Contribution to journal › Article
-
Mark
Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation
(
- Contribution to journal › Article
- 2018
-
Mark
Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
(
- Contribution to journal › Article
-
Mark
Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)
(
- Contribution to journal › Article